Background Diabetes mellitus is a well recognized public health concern and projections of its future effect are alarming. It is one of the leading causes of end stage renal disease in both developed and emerging nations. The objective of the present study was to assess the progressive deterioration of renal function in Diabetes mellitus among Nepalese.
Background
Diabetic mellitus is a metabolic disorder of multiple aetiology, characterized by chronic hyperglycemia. The increase in blood glucose concentration is mainly due to insulin deficiency or ineffectiveness in its action, which in turn damages major systems of human body particularly blood vessels and nerves 1 . According to WHO, diabetes affects more than 170 million people worldwide, and this number will rise to 370 million by 2030 2 . About one third of those affected will eventually have progressive deterioration of renal function 3 . Factors such as sedentary lifestyle, dietary modifications, genetic mutations, ethnicity, hypertension and obesity have led to a dramatic increase in the incidence of Diabetes mellitus, especially in the 21st century 4 . Diabetes is now the major cause of end stage kidney failure throughout the world in both developed and emerging nations. Chronic kidney disease usually is silent and undetected until advanced stages with adverse outcomes of kidney failure, cardiovascular disease and premature death. A strong association is well recognized between the presence of diabetes, hypertension, chronic kidney disease and cardiovascular diseases 5 . The number of patients dependent upon renal replacement therapy was approximately 400000 in year 2000 and by 2030 number is expected to increase upto 2 million in USA. More than 600000 patients require renal replacement therapy, costing around $28 billion by the year 2010 in USA 6 . The rise in prevalence, progression and complications of chronic kidney disease is probably attributable to a progressively aging population, duration of diabetes and presence of hypertension 7 . . Diabetic nephropathy is one of the most common long term sequelae of Diabetes mellitus and it is the single largest cause of end stage renal disease worldwide and accounting for 20 to 40% of new cases 10 . Diabetes mellitus is usually associated with dyslipidemia, hypertension and visceral adiposity, which collectively increases the comorbid risk of developing chronic kidney disease 5 . The current study was designed with an objective to assess the progressive deterioration of renal function in Diabetes mellitus among Nepalese in Pokhara valley.
Materials and Methods
It was a hospital based case control study carried out in the Department of Biochemistry of Manipal Teaching Hospital, Pokhara, Nepal between 1 st January 2010 and 31 st August 2010. Approval for the study was obtained from the institutional research ethical committee. Samples collected from 440 cases were analyzed in this study. The variables collected were age, gender, random blood glucose, serum urea and creatinine levels of the patients. Patients presenting to the Medicine OPD with chief complaints of oliguria, past history of Diabetes mellitus for 5 years, referred for dialysis, were taken as cases in our current study. The patients excluded were smokers, hypertensives, hyperlipidemics and pregnant women. Investigations of serum creatinine, urea and random blood sugar were sent for all of them. Subjects with normal renal function tests and random blood glucose were selected as controls.
Estimation of blood glucose was done by glucose oxidase and peroxidase method 11 . Similarly, serum urea was estimated by enzymatic method 12 while creatinine was estimated by alkaline Jaffe's Picrate method 13 . All these laboratory parameters were analyzed using Human reagent kits and with the help of semi autoanalyser (Humalyser 3500, Germany). The WHO criteria for establishing Diabetes mellitus (random blood glucose ≥200 mg/dl) was followed to categorize the people with Diabetes mellitus. The presence of kidney disease was established solely on the basis of abnormal serum urea and creatinine values. Descriptive statistics and testing of hypothesis were used for the analysis .The data collected was analyzed using Excel 2003, R 2.8.0 Statistical Package for the Social Sciences (SPSS) for Windows Version 16.0 (SPSS Inc; Chicago, IL, USA) and EPI Info 3.5.1 Windows Version. Mean and SD are reported for variables. Pearson correlation was used for assessing the degree of relationship. The Chi-square test was used to examine the association between different variables. Z-test was used to compare the significance difference between two variables. A p-value of < 0.05 (twotailed) was used to establish statistical significance. For 5% significance level, power 80%, case to control allocation 1:1, expected frequency of exposure in the not-ill group (controls) is 30%, odds ratio 2, and expected frequency of exposure in ill group (cases) is 46.15%. Sample size required was 153 cases and 153 controls with a total of 306 subjects 14 .
Results
Of the 440 patients, there was a slight predominance of males (54.1%) as compared to females (45.8%). 28.9% were diagnosed to have Diabetes mellitus and 43.2% had kidney disease. Table 1 depicts that there was quantitatively small gender differences in kidney disease patients but they were but not significant statistically (p=0.112). Patients in between 41-100 years were 2.8 times more at risk of developing kidney disease as compared to age group (0-40 years) (Odds Ratio=2.8, p=0.0001). Diabetes mellitus patients were twice at risk of kidney disease as compared to non diabetics (Odds Ratio=1.97, p=0.001). Figure 1 shows that serum urea level increases proportional to the increase in serum creatinine (r = 0.601, p=0.001).
Discussion
Diabetes mellitus is a slow, progressive disease characterized by hyperglycemia. Over time, high blood sugar levels damage millions of nephrons -tiny filtering units within each kidney. As a result, kidneys are unable to maintain the fluid and electrolyte homeostasis. Creatinine is filtered by the glomerulus; therefore, serum creatinine level is used as an indirect measure of glomerular filtration. As glomerular filtration rate (GFR) diminishes, there is a rise in plasma concentrations of serum creatinine and urea. Furthermore, this rise indicates progression of kidney disease and estimation of serum creatinine has greater pr ognostic ability compared with urea for predicting the adverse outcomes. Our present study showed significant increase in mean values of serum creatinine and urea i.e 4.6 ± SD1.18 mg/dl and 136.03 ± SD 74.6 mg/dl respectively in kidney disease patients with Diabetes mellitus. In non diabetic kidney disease patients, the mean values of serum creatinine (3.5 ± SD1.14 mg/dl) and urea (107.9 ± SD 50.4 mg/dl) were also moderately raised as compared to controls. In a similar study conducted by Shiv Kapoor et al on chronic kidney disease, mean values of serum creatinine in patients suffering from chronic kidney disease was 3.5 ± SD 2.6 mg/dl, which was almost equivalent to our non diabetic kidney disease patients 15 . The previous studies also emphasized that serum creatinine levels (2.24 ± SD0.34 mg/dl) was increased significantly in patients with diabetic nephropathy when compared to controls 16 . Therefore, raised serum urea and creatinine levels in diabetics clearly indicate that prolonged hyperglycaemia causes irreversible damage to nephrons of kidney. Raised serum creatinine and reduced GFR has become firmly entrenched as fairly reliable indicators of kidney dysfunction. Another important finding of our present study was that the mean values obtained for serum creatinine (1.13 ± SD 0.20 mg/dl) in diabetic subjects with no kidney disease were mildly increased when compared to normal patients (1.03 ± SD0.07mg/dl). The above results corresponded with findings of Puepet et al (2003) 17 . In similar studies done previously, no significant elevation in mean value of serum creatinine was observed in diabetic patients without nephropathy (1.28 ± SD 0.43mg/dl) when compared to controls (1.22 ± SD 0.55mg/dl) 16 . In our current study, patients in between 41-100 years were 2.8 times more at risk of developing kidney disease as compared to age group (0-40 years). The prevalence of chronic kidney disease is indeed rising consistently with ageing of the general population 18 . Hypertension is a known risk factor for kidney disease and people with diabetes are prone to hypertension. Genetic predisposition to hypertension is associated with an increased risk of diabetic nephropathy. Kidneys affected by diabetic nephropathy no longer work efficiently. Hyperglycemia is a precondition for developing two major early glomerular lesions, glomerular basement membrane (GBM) thickening and mesangial expansion, which are not present at the diagnosis of Diabetes but are found 2 to 5 yrs after onset of hyperglycemia there is non enzymatic glycation/oxidation of aminoacids, lipids and lipoproteins. The formation of advanced glycation end-products (AGEs) has long been recognized as a fundamental mechanism of cellular injury in diabetes. The accumulation of AGEs accelerates atherogenesis, increased vascular permeability, basement membrane thickening, increased extracellular matrix and mesangial fibrosis. This process leads the way to eventual glomerulosclerosis and renal failure 20 . Only 97 hemodialysis machines are available for renal replacement therapy in Nepal 21 . Therefore, early therapeutic interventions in patients with chronic kidney disease or diabetes can delay onset of complications, reduce mortality and overcome the cost of renal replacement therapy in Nepal.
Conclusion
The current study reveals a compelling association between diabetic mellitus and chronic kidney disease. Diabetic renal lesions are not only preventable but also reversible. In summary, glycemic control significantly influences the rate of progression from microalbuminuria to proteinuria and from overt nephropathy to end stage renal disease. The best modality of treatment includes strict control over blood glucose levels and its evaluation at frequent intervals. Simple, cheap and reliable biochemical parameters should be used in countries having low socioeconomic status with less sophisticated health systems like Nepal for screening such as estimation of serum urea, creatinine, blood glucose levels and measuring of blood pressure. Therefore, it is time for health care programmes to facilitate early detection and treatment of people suffering from Diabetes mellitus and chronic kidney disease.
